Nan D, Abraira-Meriel C, de la Roz-Fernandez S, Maestre-Orozco T, Hernandez JL, Fernandez-Ayala M. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report. EJCRIM [Internet]. 2021 Oct. 8 [cited 2026 Nov. 3];8(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2821